Antiretroviral therapy coverage in Latin America & Caribbean
Latin America & Caribbean: Antiretroviral therapy coverage was 71.6% in 2024. ▲ Rising
Antiretroviral therapy coverage in Latin America & Caribbean, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Latin America & Caribbean is 71.6%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 3.1% on the previous year and up 53.5% over ten years.
Over the whole period, antiretroviral therapy coverage in Latin America & Caribbean peaked at 71.6% in 2024 and was at its lowest, 10.9%, in 2000.
Latin America & Caribbean ranks 19th of 23 groups on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage in Latin America & Caribbean, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 10.9% | — |
| 2001 | 13.1% | +20.5% |
| 2002 | 15.0% | +14.4% |
| 2003 | 17.6% | +17.4% |
| 2004 | 19.6% | +11.1% |
| 2005 | 22.2% | +13.3% |
| 2006 | 24.4% | +9.8% |
| 2007 | 26.4% | +8.3% |
| 2008 | 28.5% | +7.9% |
| 2009 | 31.4% | +10.1% |
| 2010 | 34.9% | +11.2% |
| 2011 | 37.5% | +7.5% |
| 2012 | 40.8% | +8.9% |
| 2013 | 43.7% | +7.1% |
| 2014 | 46.7% | +6.8% |
| 2015 | 51.4% | +10.1% |
| 2016 | 53.4% | +4.0% |
| 2017 | 56.3% | +5.4% |
| 2018 | 59.0% | +4.8% |
| 2019 | 62.9% | +6.6% |
| 2020 | 65.1% | +3.5% |
| 2021 | 66.7% | +2.4% |
| 2022 | 68.0% | +2.0% |
| 2023 | 69.5% | +2.2% |
| 2024 | 71.6% | +3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.9% | 10.9% | 31.4% | 10 |
| 2010s | 48.7% | 34.9% | 62.9% | 10 |
| 2020s | 68.2% | 65.1% | 71.6% | 5 |
Countries ranked near Latin America & Caribbean
More health data for Latin America & Caribbean
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 1.43 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0359 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.16 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0369 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.903 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0377 units per person (2025)
- Population ages 30-34, female, annual growth rate 0.2931 % change on previous year (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Latin America & Caribbean?
- Antiretroviral therapy coverage in Latin America & Caribbean was 71.6% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Latin America & Caribbean?
- The highest recorded value was 71.6% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Latin America & Caribbean?
- The lowest recorded value was 10.9% in 2000.
- How does Latin America & Caribbean rank for antiretroviral therapy coverage?
- Latin America & Caribbean ranks 19th out of 23 groups with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Latin America & Caribbean?
- Over the last ten years it is up 53.5%. The long-run trend across the full record is rising.
- Where does this Latin America & Caribbean data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.